Skip to main content

Animations

MJFF Publications

661 - 670 of 8825 Results
Title
Year
  • Year
  • 2022
  • 2018
  • 2016
  • 2019
  • 2019
  • 2019
  • 2022
  • 2021
  • 2022
  • 2021
  • New dopaminergic therapies for PD motor complications
    2022
    Summary Details
    RESTRICTED
    Title: New dopaminergic therapies for PD motor complications
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108869
    Citation Count: 8
  • The genetics of Parkinson disease
    2018
    Summary Details
    RESTRICTED
    Title: The genetics of Parkinson disease
    Journal Name: Ageing Research Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.arr.2017.12.007
    Citation Count: 386
  • Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillations
    2016
    Summary Details
    RESTRICTED
    Title: Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26837
    Citation Count: 63
  • Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease
    2019
    Summary Details
    RESTRICTED
    Title: Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease
    Journal Name: Biology of the Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/boc.201800068
    Citation Count: 36
  • Summary Details
    RESTRICTED
    Title: Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms20010141
    Citation Count: 55
  • Summary Details
    RESTRICTED
    Title: Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.016
    Citation Count: 129
  • Summary Details
    RESTRICTED
    Title: Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom12070957
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom12010040
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Prodromal Cognitive Deficits and the Risk of Subsequent Parkinson’s Disease
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci12020199
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: A New Rise of Non-Human Primate Models of Synucleinopathies
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines9030272
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.